82 completed, 4 terminated, 2 not yet recruiting, 1 no longer available. 36 Phase 4, 6 Phase 1, 4 Phase 3, 2 Phase 2, 1 Not applicable.
By phase and status
Follow Janssen Korea, Ltd., Korea: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|
A Study of Opsynvi in Adults Participants With Pulmonary Arterial Hypertension in Korea
Pulmonary Arterial Hypertension | | Not yet recruiting | Janssen Korea, Ltd., Korea | 333 | 2026-11-02 | 2026-10-22 |
A Study of Radical Cystectomy in Participants With Non-Muscle Invasive Bladder Cancer (NMIBC) and Muscle Invasive Bladder Cancer (MIBC) in Korea
Urinary Bladder Neoplasms | | Not yet recruiting | Janssen Korea, Ltd., Korea | 1 | 2026-09-30 | 2026-09-25 |
A Database Study of Disease, Treatment Patterns and Healthcare Use in Children With Inflammatory Bowel Diseases in Korea
Inflammatory Bowel Diseases | | Recruiting | Janssen Korea, Ltd., Korea | 8000 | 2026-04-07 | 2026-08-28 |
A Study of Esketamine Nasal Spray in Korean Participants With Treatment-resistant Depression
Esketamine 56 mg, Esketamine 84 mg - Depressive Disorder, Treatment-Resistant | Phase 4 | Completed | Janssen Korea, Ltd., Korea | 47 | 2025-06-09 | 2026-08-03 |
A Study to Investigate the Comparative Effectiveness of Ibrutinib in Steroid Dependent/Refractory cGVHD Participants
Chronic Graft vs Host Disease | | Terminated | Janssen Korea, Ltd., Korea | 15 | 2021-06-21 | 2025-05-23 |
A Study of the Newly Formulated Tylenol Tablet (Acetaminophen) to the Tylenol 8 Hour (H) Extended Release (ER) Tablet (Acetaminophen) in Healthy Participants
Acetaminophen - Healthy | Phase 1 | Completed | Janssen Korea, Ltd., Korea | 30 | 2020-01-07 | 2025-04-27 |
A Study of Newly Formulated Tylenol Tablet (Acetaminophen) and Tylenol 8 Hour (H) Extended Release (ER) Tablet (Acetaminophen) in Healthy Participants
Acetaminophen - Healthy | Phase 1 | Completed | Janssen Korea, Ltd., Korea | 30 | 2019-12-17 | 2025-04-27 |
Post-Marketing Surveillance for Crohn's Disease Participants Treated With Stelara (Ustekinumab)
Ustekinumab - Crohn Disease | | Completed | Janssen Korea, Ltd., Korea | 685 | 2019-04-08 | 2025-04-27 |
A Study to Evaluate Efficacy and Safety of Infliximab in Participant With Moderate-to-Severe Refractory Intestinal Behcet's Disease
Infliximab - Behcet Disease | Phase 3 | Completed | Janssen Korea, Ltd., Korea | 33 | 2015-07-22 | 2019-10-17 |
Study of Clinical Course of Newly Diagnosed Moderate to Severe Ulcerative Colitis in Korea
No Intervention - Colitis, Ulcerative | | Completed | Janssen Korea, Ltd., Korea | 368 | 2014-07-01 | 2025-04-27 |
Evaluate Retention Rate of Topiramate, Levetiracetam and Oxcarbazepine in a Long-term Epilepsy Treatment
Epilepsy | | Unknown | Seoul National University Hospital | 2500 | 2014-03-01 | 2014-03-28 |
A Study to Assess the Bioequivalence of a New ULTRACET Extended Release (ER) Tablet With Respect to a Marketed ULTRACET ER Tablet Under Fasted Condition
Tramadol HCl 75 mg/Acetaminophen 650 mg (Newly developed ULTRACET ER), Tramadol HCl 75 mg/Acetaminophen 650 mg (Marketed ULTRACET ER) - Healthy | Phase 1 | Completed | Janssen Korea, Ltd., Korea | 56 | 2012-12-01 | 2014-02-10 |
A Post Marketing Survey Study to Evaluate the Safety and Effectiveness of Intelence
No intervention - Acquired Immune Deficiency Syndrome | | Completed | Janssen Korea, Ltd., Korea | 57 | 2012-09-01 | 2016-04-04 |
An Observational Study to Evaluate the Quality of Life in Korean Female Participants With Chronic Constipation
Prucalopride; observational study - Constipation | | Completed | Janssen Korea, Ltd., Korea | 150 | 2012-08-01 | 2013-07-18 |
A Post Marketing Survey Study to Evaluate the Safety and Effectiveness of Prezista
No intervention - Acquired Immune Deficiency Syndrome | | Completed | Janssen Korea, Ltd., Korea | 225 | 2012-07-01 | 2016-12-05 |
A Comparative Study of Patient Satisfaction Between Continued Administration of Previous Antipsychotics Versus Switched Administration to Paliperidone ER in Non-satisfied Patients With Previous Antipsychotic Drug
Paliperdidone ER, Aripiprazole, olanzapine and risperidone (Antipsychotics) - Schizophrenia | Phase 4 | Terminated | Janssen Korea, Ltd., Korea | 13 | 2012-07-01 | 2014-06-25 |
A Study to Examine the Progression of Attention-Deficit Hyperactivity Disorder (ADHD) Drug Treatment and to Analyze Associated Factors
Methylphenidate hydrochloride, Atomoxetine - Attention-deficit Hyperactivity Disorder | | Completed | Janssen Korea, Ltd., Korea | 289 | 2012-02-01 | 2015-06-09 |
The Effectiveness of a Patient Self-reported Pain Scoring Tool and a Satisfaction Survey on Cancer Pain Management
No intervention - Pain | | Completed | Janssen Korea, Ltd., Korea | 587 | 2012-01-01 | 2013-04-11 |
A Comparative Study to Evaluate the Evolution of Medication Satisfaction and Adherence in Patients Unsatisfied With Current Oral Atypical Antipsychotics by Switching Medication to Paliperidone Palmitate
Paliperidone palmitate - Schizophrenia | Phase 4 | Completed | Janssen Korea, Ltd., Korea | 154 | 2012-01-01 | 2014-08-01 |
The Effectiveness and Tolerability of Fentanyl Matrix in Chronic Non-cancer Pain; Assessment of Patient's Pain Treatment Goal Achievement
Fentanyl matrix - Chronic Pain | | Completed | Janssen Korea, Ltd., Korea | 410 | 2011-12-01 | 2013-11-21 |
Showing 20 of 91. Sign in to see all of them.
Conditions studied
Schizophrenia (13) · Pain (11) · Cancer Pain (8) · Multiple Myeloma (6) · Chronic Pain (5) · Alzheimer Disease (4) · Epilepsy (4) · Arthritis, Rheumatoid (3) · Attention Deficit Disorder with Hyperactivity (3) · Hematologic Neoplasms (3) · Mental Disorders (3) · Myelodysplastic Syndromes (3) · Neutropenia (3) · Osteoarthritis (3) · Acquired Immunodeficiency Syndrome (2)
Interventions
Paliperidone Palmitate (8) · Risperidone (7) · Bortezomib (6) · Acetaminophen (5) · Rabeprazole (5) · Ultracet (5) · Galantamine (4) · Infliximab (3) · Itraconazole (3) · Methylphenidate (3) · Topiramate (3) · Tramadol (3) · Decitabine (2) · Fentanyl (2) · Observation (2)
Countries
South Korea (43) · Brazil (1) · Hong Kong (1) · Thailand (1)
Top investigators
Cheolwon Suh, M.D.,Ph.D. (1) · Dae Hyun Kim, Prof (1) · Doh Kwan Kim, PhD, M.D. (1) · Hiun-Suk Chae, Professor (1) · Jin-Sang Yoon, Professor (1) · MyungKu Choi, MD (1) · Sang Kun Lee, MD, PhD (1) · Young-Chul Kim, MD,PhD (1)
Results publications
PMID 31375393, PMID 20821238, PMID 21659363, PMID 21733227, PMID 22516251, PMID 22809972, PMID 23587983, PMID 24183364, PMID 24431907, PMID 24583566, PMID 25299350, PMID 27822929, PMID 33945627, PMID 36578194, PMID 39096895